GlucoTrack (GCTK) Appoints John Ballantyne to its Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/31/2026

1. INTC
2. AMZN
3. RDDT
4. COIN
5. PINS
6. FSLR
7. SYK
8. GILD
9. SBUX
10. SNDK

Go back to GlucoTrack (GCTK) Appoints John Ballantyne to its Board

JOHN BALLANTYNE, FORMER BIOTECHNOLOGY EXECUTIVE, JOINS THE GLUCOTRACK BOARD OF DIRECTORS

September 3, 2024 9:00 AM EDT

Biotech veteran joins Glucotracks Board to support bringing novel continuous blood glucose monitoring technology to people with diabetes

Rutherford, NJ, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (Glucotrack or the Company), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced the appointment of John Ballantyne, PhD to its Board of Directors, effective immediately.

We are pleased to welcome John, who has been a long-standing supporter of the Company, to our Board of Directors,"... More